SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 1,593.21 |
| Enterprise Value ($M) | 1,210.80 |
| Book Value ($M) | 1,779.09 |
| Book Value / Share | 47.34 |
| Price / Book | 0.90 |
| NCAV ($M) | 963.32 |
| NCAV / Share | 25.63 |
| Price / NCAV | 1.65 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.03 |
| Return on Assets (ROA) | 0.02 |
| Return on Equity (ROE) | 0.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.03 |
| Current Ratio | 3.60 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 1,347.40 |
| Assets | 2,163.18 |
| Liabilities | 384.09 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Sun Pharmaceutical Industries Ltd | 78.48 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,755 | 27,152 | 6.46 | |
| 2,495 | 36,016 | 6.93 | |
| 5,235 | 25,018 | 20.92 | |
| 4,334 | 57,092 | 7.59 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PRGO – Perrigo Company plc | QGEN – Qiagen N.V. |
| RCUS – Arcus Biosciences, Inc. | USNA – USANA Health Sciences, Inc. |
Financial data and stock pages provided by
Fintel.io